Fig. 4

Mutation landscape of APOF and RNA modification. A Mutation landscapes of APOF for BRCA and LIHC; B the top 15 mutation genes between high and low-expression group for BRCA patients, including PIK3CA, TP53, KMT2C, MUC17, SRCAP, OBSCN, CENPE, UBR5, GPS2; C the top 15 mutation genes between high and low-expression group for PRAD patients, including TP53, SPOP, FOXA1, TP53BP1, LRRTM1 and ERF; D the top 15 mutation genes between high and low-expression group for KIRP patients, including TP53, SPOP, FOXA1, TP53BP1, LRRTM1 and ERF; E the top 15 mutation genes between high and low-expression group for LIHC patients. BAP1, RB1, SPEG, IRS4, COL15A1, STK32B, RP1L1, EPG5, TLR8 and CHSY3 mutations were significant; F the correlation of APOF expression and RNA modification genes